PERBANDINGAN SENSITIVITAS ANTIBIOTIK MINOSIKLIN DAN ERITROMISIN TERHADAP BAKTERI Propionibacterium acnes PENYEBAB ACNE VULGARIS
DOI:
https://doi.org/10.59003/nhj.v2i11.820Keywords:
Propionibacterium acnes, Minocycline, Erythromycin, Acne vulgarisAbstract
Acne vulgaris is a common skin disease that people complain about. Acne vulgaris is generally caused by Propionibacterium acnes bacterial infection. Treatment of Acne vulgaris can use antibiotics such as Minocycline and Erythromycin. Long-term use of antibiotics can lead to an increase in the occurrence of resistance. Research objective to determine the difference in sensitivity of Minocycline and Erythromycin antibiotics to Propionibacterium acnes bacteria that cause Acne vulgaris. This study used a type of laboratory pre-experimental research with a one-shot case study design. The research was conducted at the Health Laboratory Testing and Calibration Center (BLKPK) of NTB Province in February 2023. The sample used was Propionibacterium acnes bacteria. The data obtained were analyzed with the Independent t-test test. The results of Propionibacterium acnes bacteria are sensitive to Minocycline antibiotics with an average inhibition zone diameter of 22.8 mm and Erythromycin with an average inhibition zone diameter of 24.2 mm. Independent t-test results obtained a p-value of 0,688 which states there is no significant difference between the sensitivity of P. acnes bacteria to Minocycline and Erythromycin antibiotics. There is no difference in the sensitivity of Minocycline and Erythromycin antibiotics to Propionibacterium acnes bacteria that cause Acne vulgaris.
Downloads
References
Asadi, A., Abdi, M., Kouhsari, E., Panahi, P., Sholeh, M., Sadeghifard, N., Amiriani, T., Ahmadi, A., Maleki, A., & Gholami, M. 2020. Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future. Journal of Global Antimicrobial Resistance, 22, 161–174. https://doi.org/10.1016/j.jgar.2020.01.022
Asditya, A., Zulkarnain, I., & Dkk. 2019. Uji Kepekaan Antibiotik Oral terhadap Bakteri Propionilbacterium acnes Pasien Akne Vulgaris Derajat Sedang Berat. Periodical of Dermatology and Venerology, 31(3), 128–135.
Dekotyanti, T. 2020. Efektifitas Antibiotik Eritromisin Terhadap Bakteri Propionibacterium Acnes Dengan Metode Difusi Pada Acne Vulgaris. Molucca Medica, 15(1), 74-83.
https://doi.org/10.30598/molmed.2022.v15.i1.74
Fadilah, A. A. 2021. Hubungan Stres Psikologis Terhadap Timbulnya Akne Vulgaris. Jurnal Ilmiah Kesehatan Sandi Husada, 10(2), 390–395. https://doi.org/10.35816/jiskh.v10i2.625
Febyan, & Wetarini, K. 2020. Acne Vulgaris in Adults: A Brief Review on Diagnosis and Management. International Journal of Research and Review (Ijrrjournal.Com), 7(5), 5. www.ijrrjournal.com
Kamala, M. F., & Farmakologi, B. 2020. Sensitivitas Antibiotik Paten Dan Generik Terhadap Beberapa Bakteri Penyebab Jerawat. 1(2), 78–86.
Madelina, W., & Sulistiyaningsih. 2018. Review: Resistensi Antibiotik pada Terapi Pengobatan Jerawat. Jurnal Farmaka, 16(2), 105–117.
Menaldi, S. L. S. (2016). Ilmu Penyakit Kulit dan Kelamin. Fakultas Kedokteran Universitas Indonesia.
Onge, E. S., & Mobley, W. C. 2021. Minocycline Topical Foam: A New Drug for the Treatment of Acne. Annals of Pharmacotherapy, 55(1), 105–110. https://doi.org/10.1177/1060028020939926
Akramullah, S., Pramuningtyas, R., Kedokteran, F., & Muhammadiyah, U. 2017. Review Analisis Efektivitas Terapi Antibiotik Akne. 192–200.
Sari, L. 2019. Identifikasi Bakteri pada Lesi Akne Vulgaris. Repositori Institusi USU.
Sesanti, R. T., & Pramuningtyas, R. 2021. Hubungan tingkat stres dan pemakaian bb cream dengan kejadian akne vulgaris pada mahasiswi fakultas kedokteran universitas muhammadiyah surakarta tahun 2021. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9(1), 1–7.
Sibero, H. T., Putra, I. W. A., & Anggraini, D. I. 2019. Tatalaksana Terkini Acne Vulgaris Current Management of Acne Vulgaris. 3, 313–320.
Siva, F., & Adriana, Y. 2019. Potensi Antibiotik Dan Uji Difusi Secara in Vitro Pada Formulasi Krim Eritromisin. Jurnal Medical Profession, 3(3), 277–282.
Wibisono, E. A., Indramaya, D. M., & Rochmanti, M. 2020. Retrospective Study: Initial Pharmacotherapy Profile of New Acne Vulgaris Patients. Jurnal Berkala Epidemiologi, 8(3), 236. https://doi.org/10.20473/jbe.v8i32020.236-245
Yenny, S. W. 2019. Resistensi Antibiotik Pada Pengobatan Akne Vulgaris. Media Dermato Venereologica Indonesiana, 45(2), 111–115. https://doi.org/10.33820/mdvi.v45i2.24
Zhu, T., Zhu, W., Wang, Q., He, L., Wu, W., Liu, J., Li, Y., & Sun, D. 2019. Antibiotic susceptibility of Propionibacterium acnes isolated from patients with acne in a public hospital in Southwest China: Prospective cross-sectional study. BMJ Open, 9(2), 1–7. https://doi.org/10.1136/bmjopen-2018-022938
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Syavira Adinda Widiastuti
This work is licensed under a Creative Commons Attribution 4.0 International License.
NHJ is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles in this journal are Open Access articles published under the Creative Commons CC BY-NC-SA License This license permits use, distribution and reproduction in any medium for non-commercial purposes only, provided the original work and source is properly cited.
Any derivative of the original must be distributed under the same license as the original.
